Pulmonary administration of chemically modified insulin

Details for Australian Patent Application No. 2002303869 (hide)

Owner Nektar Therapeutics Nektar Therapeutics AL, Corporation

Inventors Patton, John, S.; BUECHE, Blaine; Harris, J., Milton; Kuo, Mei-Chang; Perkins, Kimberly; Leach, Chester

Agent Griffith Hack

Pub. Number AU-B-2002303869

PCT Number PCT/US02/16464

PCT Pub. Number WO2002/094200

Priority 60/292,423 21.05.01 US

Filing date 21 May 2002

Wipo publication date 3 December 2002

Acceptance publication date 16 August 2007

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 9/24 (2006.01) Medicinal preparations characterised by special physical form - Layered or laminated unitary dosage forms

A61K 9/72 (2006.01) Medicinal preparations characterised by special physical form - for smoking or inhaling

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/28 (2006.01) Medicinal preparations containing peptides - Insulins

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61L 9/04 (2006.01) Disinfection, sterilisation or deodorisation of air - using substances evaporated in the air without heating

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07K 14/62 (2006.01) Peptides having more than 20 amino acids

Event Publications

12 December 2002 Complete Application Filed

  Priority application(s): 60/292,423 21.05.01 US

8 May 2003 Application Open to Public Inspection

  Published as AU-B-2002303869

11 December 2003 Assignment before Grant

  Inhale Therapeutic System Inc; Nektar Therapeutics AL, Corporation The application has been assigned to Nektar Therapeutics; Nektar Therapeutics AL, Corporation

11 December 2003 Change of Name(s) of Applicant(s), Section 104

  Inhale Therapeutic Systems, Inc.; Shearwater Corporation The name of the applicant has been changed to Inhale Therapeutic Systems, Inc.; Nektar Therapeutics AL, Corporation

16 August 2007 Application Accepted

  Published as AU-B-2002303869

13 December 2007 Standard Patent Sealed

16 July 2009 Assignment Registered

  Nektar Therapeutics AL, Corporation; Nektar Therapeutics The patent has been assigned to Novartis AG

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002303870-NUCLEOTIDE COMPOUNDS THAT BLOCK THE BITTER TASTE OF ORAL COMPOSITIONS

2002303868-Delivery of antihistamines through an inhalation route